Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/NANEXA stock hub

STO/NANEXA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

STO/NANEXAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
666.2M
Nasdaq Stockholm
Market data

Live price

Current market quote for this ticker.

Current price
STO/NANEXA
In the news

Latest news · STO/NANEXA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-14.8
P25 n/aP50 n/aP75 n/a
ROIC-6.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All STO/NANEXA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
186
Groups with data
11
Currency
SEK
Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Sweden
Country code
SE
Employees
15
Employees Change
-1%
Employees Change Percent
-6.25
Enterprise value
SEK 594.1M
Exchange
Nasdaq Stockholm
Financial currency
SEK
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
SE0007074166
Last refreshed
2026-05-10
Market cap
SEK 666.2M
Price
SEK 3.61
Price currency
SEK
Rev Per Employee
3,621,333.33x
Sector
Healthcare
Sic
3841
Symbol
sto/NANEXA
Website
https://nanexa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-2.47%
EV Earnings
-36.17x
EV/FCF
4,678.11x
EV/Sales
10.94x
FCF yield
0.02%
P/B ratio
5.24x
P/S ratio
12.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-24.89%
EBITDA Margin
-16.78%
FCF margin
0.23%
Gross margin
75.38%
Gross Profit
SEK 40.9M
Gross Profit Growth
63.79%
Gross Profit Growth Q
-28.06%
Gross Profit Growth3 Y
58.52%
Gross Profit Growth5 Y
51.6%
Net Income
SEK -16.4M
Net Income Growth Years
2%
Pretax Margin
-30.43%
Profit Margin
-30.24%
Profit Per Employee
SEK -1.1M
ROA
-5.66
Roa5y
-18.54
ROCE
-10.55
ROE
-14.84
Roe5y
-39.92
ROIC
-6.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
-8.03%
Cagr1y
100.6%
Cagr3y
0.23%
Cagr5y
-15.93%
EPS Growth Years
3
Revenue Growth
34.38x
Revenue Growth Q
-19.59x
Revenue Growth Years
1x
Revenue Growth3 Y
15.33x
Revenue Growth5 Y
19.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
SEK 0.36
Assets
SEK 166.7M
Cash
SEK 73M
Current Assets
SEK 79.7M
Current Liabilities
SEK 38.6M
Debt
SEK 987,000
Debt Equity
SEK 0.01
Debt FCF
SEK 7.77
Equity
SEK 127.1M
Interest Coverage
-4.63
Liabilities
SEK 39.6M
Long Term Assets
SEK 87M
Long Term Liabilities
SEK 987,000
Net Cash
SEK 72M
Net Cash By Market Cap
SEK 10.81
Net Cash Growth
163.56%
Net Debt Equity
SEK -0.57
Net Debt FCF
SEK -567
Tangible Book Value
SEK 49.8M
Tangible Book Value Per Share
SEK 0.28
WACC
14.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.06
Inventory Turnover
387.7
Net Working Capital
SEK -31.9M
Quick ratio
2.06
Working Capital
SEK 41.1M
Working Capital Turnover
SEK 1.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-16.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-56.69%
1Y total return
100.5%
200-day SMA
2.87
3Y total return
0.7%
50-day SMA
3.77
50-day SMA vs 200-day SMA
50over200
5Y total return
-58%
All Time High
16.09
All Time High Change
-77.6%
All Time High Date
2015-11-12
All Time Low
0.6
All Time Low Change
500.83%
All Time Low Date
2024-04-17
ATR
0.2
Beta
1.75
Beta1y
0.25
Beta2y
0.76
Ch YTD
-18.99
High
3.75
High52
5
High52 Date
2025-12-30
High52ch
-27.9%
Low
3.6
Low52
1.4
Low52 Date
2025-11-06
Low52ch
157.5%
Ma50ch
-4.3%
Price vs 200-day SMA
25.61%
RSI
46.76
RSI Monthly
58.52
RSI Weekly
56.45
Sharpe ratio
1.32x
Sortino ratio
2.57
Total Return
-16.56%
Tr YTD
-18.99
Tr1m
-2.04%
Tr1w
7.93%
Tr3m
-3.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
SEK -13.5M
Operating margin
-24.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
140,013,151%
Net Borrowing
-1,508,000
Shares Insiders
9.62%
Shares Institutions
15.17%
Shares Out
184,786,535
Shares Qo Q
10.17%
Shares Yo Y
16.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
SEK 127,000
Average Volume
639,787.9x
Bv Per Share
0.73
CAPEX
SEK -102,000
Ch10y
-59.67
Ch1m
-2.04
Ch1w
7.93
Ch1y
100.5
Ch3m
-3.48
Ch3y
0.7
Ch5y
-60.9
Ch6m
123.9
Change
-1.64%
Change From Open
0.28
Close
3.67
Days Gap
-1.91
Depreciation Amortization
4,402,500
Dollar Volume
1,202,833.5
Earnings Date
2026-04-29
EBIT
SEK -13.5M
EBITDA
SEK -9.1M
EPS
SEK -0.1
F Score
5
FCF
SEK 127,000
FCF EV Yield
0.02x
FCF Per Share
SEK 0
Financing CF
47,847,000
Fiscal Year End
December
Founded
2,007
Income Tax
SEK -108,000
Investing CF
-24,269,000
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2017-10-31
Last Split Type
Forward
Ma150
3.08
Ma150ch
16.89%
Ma20
3.72
Ma20ch
-2.96%
Net CF
23,806,000
Next Earnings Date
2026-08-27
Open
3.6
P FCF Ratio
5,245.3
P OCF Ratio
2,909
Position In Range
6.45
Ppne
9,281,000
Price Date
2026-05-08
Ptbv Ratio
13.37
Relative Volume
0.51x
Revenue
54,320,000x
Tax By Revenue
-0.2x
Tr6m
123.91%
Volume
333,657
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does STO/NANEXA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/NANEXA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+100.5%
S&P 500 1Y: n/a
3Y total return
+0.7%
S&P 500 3Y: n/a
5Y total return
-58.0%
S&P 500 5Y: n/a
10Y total return
-56.7%
S&P 500 10Y: n/a
Ownership

Who owns STO/NANEXA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.2%
Share of float held by funds and institutions
Insider ownership
+9.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+16.6%
Negative means the company is buying back shares.
Technical

STO/NANEXA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.8
Neutral momentum band
Price vs 200-day MA
+25.6%
50/200-day relationship not available
Beta (5Y)
1.75
More volatile than the market
Sharpe ratio
1.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About STO/NANEXA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/NANEXA stock rating?

sto/NANEXA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/NANEXA analysis?

The full report lives at /stocks/sto/NANEXA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/NANEXA?

The latest report frames sto/NANEXA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/NANEXA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sto/NANEXA stock profile: metrics, valuation and analysis | Tác nhân AI Thị trường Chứng khoán